E-Barcelona, Spain

Ricardo D Matas


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1986-1988

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ricardo D Matas

Introduction

Ricardo D Matas is a notable inventor based in E-Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with analgesic and anti-inflammatory properties. With a total of 2 patents to his name, Matas continues to push the boundaries of innovation in his field.

Latest Patents

Matas's latest patents include the invention of 2-halo-aryl-pyridinemethanols, which exhibit analgesic or anti-inflammatory activity. These compounds are characterized by a specific formula where X can be Cl or Br, and Ar represents phenyl or substituted phenyl groups. Additionally, he has developed 2-halo-pyridines, which are defined by a general formula that includes various alkyl and halogen substituents. His inventions also encompass the production of these compounds and the pharmaceuticals that contain them.

Career Highlights

Ricardo D Matas is currently associated with Lacer, S.A., a company known for its commitment to pharmaceutical innovation. His work at Lacer has allowed him to focus on the development of new therapeutic agents that can improve patient outcomes. Matas's expertise in medicinal chemistry has been instrumental in advancing the company's research initiatives.

Collaborations

Throughout his career, Matas has collaborated with esteemed colleagues such as Jose M Repolles and Jorge S Sera. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of new pharmaceutical compounds.

Conclusion

Ricardo D Matas exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborative efforts highlight his commitment to advancing medical science. Matas's work continues to pave the way for new therapeutic solutions that can benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…